Sales - Articles
Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways to cut corners on systematic reviews. Sometimes there are true efficiencies to be made. Yet, all compromises have consequences.
In this article, we delve into 11 common problems that may arise when cost-cutting compromises the quality of your systematic literature review.
1. Choosing the wrong type of systematic review methodology Selecting the wrong type of methodology for your review can have profound implications. A robust, gold standard Cochrane methodology involves two reviewers at all stages of the review, to avoid bias in the identification and presentation of the evidence, and ensur…
1. Choosing the wrong type of systematic review methodology Selecting the wrong type of methodology for your review can have profound implications. A robust, gold standard Cochrane methodology involves two reviewers at all stages of the review, to avoid bias in the identification and presentation of the evidence, and ensur…
Specialised commissioning continues to be an issue of significance and uncertainty for both the NHS and industry. What do the latest reports of regional push back on the plans for devolution to Integrated Care Boards (ICBs) mean? Learn more about our upcoming webinar here.
For the past 2 years, Pharma, Medtech, and Diagnostic companies have identified the delegation of specialised commissioning to the new Integrated Care Boards (ICBs) as a key risk to their UK market access strategies. With its importance to income and the high risk of change devolution seems to promise, specialised commissioning is an obvious issue for providers of these products to place at the top of their risk logs. The devolution plans are also a risk for the NHS. Not least, because around two-thirds of the income of a…
For the past 2 years, Pharma, Medtech, and Diagnostic companies have identified the delegation of specialised commissioning to the new Integrated Care Boards (ICBs) as a key risk to their UK market access strategies. With its importance to income and the high risk of change devolution seems to promise, specialised commissioning is an obvious issue for providers of these products to place at the top of their risk logs. The devolution plans are also a risk for the NHS. Not least, because around two-thirds of the income of a…
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have updated the reimbursement routes and added new market insights for 2023/24.
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have updated the reimbursement routes and added new market insights for 2023/24. In this introductory guide, our Global market access experts present an overview of the reimbursement landscape in key European healthcare systems. We highlight the differences between key markets and provide a high-level guide for…
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have updated the reimbursement routes and added new market insights for 2023/24. In this introductory guide, our Global market access experts present an overview of the reimbursement landscape in key European healthcare systems. We highlight the differences between key markets and provide a high-level guide for…
Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an overview of the EU Joint Clinical Assessment (JCA) and what it means for Pharma and Medical Device manufacturers launching new technologies from 2025.
What is the EU JCA? In January 2022, the European Parliament enacted a new EU Health Technology Assessment (HTA) Regulation, with the aim of standardising clinical assessment of medicines and high-risk medical devices across the EU and avoiding duplication of work. Currently, Pharma and Medtech manufacturers have to submit evidence individually in each of the 27 EU markets; the intention of the JCA is that at least some of the assessment can be done centrally. The JCA report will act as a universal information source for relative treatment effects, safety…
What is the EU JCA? In January 2022, the European Parliament enacted a new EU Health Technology Assessment (HTA) Regulation, with the aim of standardising clinical assessment of medicines and high-risk medical devices across the EU and avoiding duplication of work. Currently, Pharma and Medtech manufacturers have to submit evidence individually in each of the 27 EU markets; the intention of the JCA is that at least some of the assessment can be done centrally. The JCA report will act as a universal information source for relative treatment effects, safety…
DLL3 (DELTA-LIKE Protein 3) is encoded by the human gene and belongs to the Delta-Like protein family. It is a transmembrane protein involved in cell signaling, cell fate determination, and cell differentiation.
The Delta-Like protein family comprises ligands that interact with NOTCH receptors, crucial for cell development and differentiation. DLL3 plays a pivotal role in neurogenesis, contributing to the generation of neurons during embryonic development.
DLL3 has garnered significant interest in cancer research, particularly in certain types of cancer. Elevated DLL3 expression has been detected in some small cell lung cancer (SCLC) and other neuroendocrine tumors. As a result, targeted treatment approaches have been developed to inhibit DLL3, providing a potential treatment strategy for these aggressive cancers.
The biotech industry is a large and growing field with many opportunities for those who want to pursue it professionally. The growth of this industry has been rapid in recent years, with more than 200 new products being marketed every year. In this article, we will look at the current trends in the industry and discuss how they affect marketers and consumers.
What is Biotechnology? Biotechnology is the application of biological processes and materials, including biochemistry, microbiology and molecular biology. Nobel-prize-winning chemist George Wald coined the term in 1949. Biotechnology is not the same as traditional biochemistry: it encompasses a diverse range of techniques we can use for industrial processing and research purposes. For example, it includes processes such as recombin…
What is Biotechnology? Biotechnology is the application of biological processes and materials, including biochemistry, microbiology and molecular biology. Nobel-prize-winning chemist George Wald coined the term in 1949. Biotechnology is not the same as traditional biochemistry: it encompasses a diverse range of techniques we can use for industrial processing and research purposes. For example, it includes processes such as recombin…
The biotech industry is a large and growing field with many opportunities for those who want to pursue it professionally. The growth of this industry has been rapid in recent years, with more than 200 new products being marketed every year. In this article, we will look at the current trends in the industry and discuss how they affect marketers and consumers.
What is Biotechnology? Biotechnology is the application of biological processes and materials, including biochemistry, microbiology and molecular biology. Nobel-prize-winning chemist George Wald coined the term in 1949. Biotechnology is not the same as traditional biochemistry: it encompasses a diverse range of techniques we can use for industrial processing and research purposes. For example, it includes processes such as recombin…
What is Biotechnology? Biotechnology is the application of biological processes and materials, including biochemistry, microbiology and molecular biology. Nobel-prize-winning chemist George Wald coined the term in 1949. Biotechnology is not the same as traditional biochemistry: it encompasses a diverse range of techniques we can use for industrial processing and research purposes. For example, it includes processes such as recombin…
Medicines are becoming ever more complex in response to growth in personalised treatments and the development of a wide range of therapeutics to address less common conditions or rare diseases
by Kelly Doering, Sr Director, Industry Marketing, Pharma, AspenTech Medicines are becoming ever more complex in response to growth in personalised treatments and the development of a wide range of therapeutics to address less common conditions or rare diseases. Examples of the latter include small molecules linked to large, perhaps conjugated to a chemotoxic agent for targeted cancer treatment; peptides linked to peptides; oligos linked to molecules that allow for better cell permeability; and lipid-encapsulated molecules that prevent degradation. But it is the market for more personalised medication…
by Kelly Doering, Sr Director, Industry Marketing, Pharma, AspenTech Medicines are becoming ever more complex in response to growth in personalised treatments and the development of a wide range of therapeutics to address less common conditions or rare diseases. Examples of the latter include small molecules linked to large, perhaps conjugated to a chemotoxic agent for targeted cancer treatment; peptides linked to peptides; oligos linked to molecules that allow for better cell permeability; and lipid-encapsulated molecules that prevent degradation. But it is the market for more personalised medication…
Two laboratory relocation specialists have joined forces to offer customers a seamless approach to moving samples alongside other elements of a lab.
Two laboratory relocation specialists have joined forces to offer customers a seamless approach to moving samples alongside other elements of a lab. Lab removal firm Aport and sample logistics company Biocair have teamed up to bring combined expertise to their customers’ projects. The collaboration offers simplified project management and a single point of contact. The two firms will mark the new venture with a free webinar detailing 10 steps to follow when relocating a lab, taking place on Thursday 10th June. Commercial director of Aport, Tom Wickstead, said the partnership set new standards for the industry. “We’ve worked with Biocair o…
Two laboratory relocation specialists have joined forces to offer customers a seamless approach to moving samples alongside other elements of a lab. Lab removal firm Aport and sample logistics company Biocair have teamed up to bring combined expertise to their customers’ projects. The collaboration offers simplified project management and a single point of contact. The two firms will mark the new venture with a free webinar detailing 10 steps to follow when relocating a lab, taking place on Thursday 10th June. Commercial director of Aport, Tom Wickstead, said the partnership set new standards for the industry. “We’ve worked with Biocair o…
Earlier this year the European Medicines Agency updated its guidelines, clarifying how to maintain supply of UK-registered products in Europe following December 31. Here, Cecilia Avram, Senior Regulatory Affairs Manager at Arriello, assesses what needs to change.
Earlier this year the European Medicines Agency updated its guidelines, clarifying how to maintain supply of UK-registered products in Europe following December 31. Here, Cecilia Avram, Senior Regulatory Affairs Manager at Arriello, assesses what needs to change. After months of Covid-related distractions, Brexit is back in the headlines - demanding new attention to how the life sciences industry will maintain cross-border product movement and manage regulatory administration from January 1. Updated guidelines for pharmaceuticals…
Earlier this year the European Medicines Agency updated its guidelines, clarifying how to maintain supply of UK-registered products in Europe following December 31. Here, Cecilia Avram, Senior Regulatory Affairs Manager at Arriello, assesses what needs to change. After months of Covid-related distractions, Brexit is back in the headlines - demanding new attention to how the life sciences industry will maintain cross-border product movement and manage regulatory administration from January 1. Updated guidelines for pharmaceuticals…
Data-sharing is crucial for any supply chain activity. But for drug manufacturing and the pharmaceutical sector, it has to be top-notch because the process is multi-layered and complicated. Considering the DSCSA guidance with the aim to combat circulation of counterfeit medicines, information-sharing in this particular sector should not just be streamlined but also be fast and secured. While error-free serialization is a pre-requisite for pharmaceutical track and trace under DSCSA compliance norms, the information in the form of data encryption is a mandate to increase the efficiency and security of the pharmaceutical supply chain.
Pharmaceutical Track and Trace: Sharing the Right Data for a Competent Supply Chain Management Data-sharing is crucial for any supply chain activity. But for dr…
Pharmaceutical Track and Trace: Sharing the Right Data for a Competent Supply Chain Management Data-sharing is crucial for any supply chain activity. But for dr…
08-Oct-2019
Here are the top Pharma and Life Science recruitment organisations advertising in September on PharmiWeb.jobs.
Barrington James Clinical - 206 Jobs RBW Consulting - 163 Jobs i-Pharm Consulting - 141 Jobs CHASE - 133 Jobs SEC Recruitment - 116 Jobs ID Search & Selection - 86 Jobs Clinical Professionals Ltd - 85 Jobs Hobson Prior - 76 Jobs CK Clinical - 68 Jobs Barrington James Europe - 63 Jobs X4 Life Sciences - 63 Jobs Advanced Regulatory (UK & Europe) - 60 Jobs Barrington James Medical / Executive - 58 Jobs Thornshaw Recruitment - 56 Jobs Barrington James Scientific - 48 Jobs Only Medics Recruitment ltd - 46 Jobs Planet Pharma Staffing Limited - 45 Jobs Umbilical Life - 44 Jobs ProClinical Ltd - 39 Jobs CTC Resourcing Solutions - 34 Jobs Volt - 31 Jobs Haybury - 31 Jobs Advanced S…
Barrington James Clinical - 206 Jobs RBW Consulting - 163 Jobs i-Pharm Consulting - 141 Jobs CHASE - 133 Jobs SEC Recruitment - 116 Jobs ID Search & Selection - 86 Jobs Clinical Professionals Ltd - 85 Jobs Hobson Prior - 76 Jobs CK Clinical - 68 Jobs Barrington James Europe - 63 Jobs X4 Life Sciences - 63 Jobs Advanced Regulatory (UK & Europe) - 60 Jobs Barrington James Medical / Executive - 58 Jobs Thornshaw Recruitment - 56 Jobs Barrington James Scientific - 48 Jobs Only Medics Recruitment ltd - 46 Jobs Planet Pharma Staffing Limited - 45 Jobs Umbilical Life - 44 Jobs ProClinical Ltd - 39 Jobs CTC Resourcing Solutions - 34 Jobs Volt - 31 Jobs Haybury - 31 Jobs Advanced S…
08-Oct-2019
A list of the TOP Pharma Companies who are hiring this month (September)
Covance - 388 Jobs BSI Group - 167 Jobs PRA Health Sciences - 105 Jobs PPD- 81 Jobs Roche - 77 Jobs Synteract- 74 Jobs United BioSource Corporation. - 69 Jobs Cytel - 68 Jobs Syneos Health - 52 Jobs CROMSOURCE - 51 Jobs IQVIA - 36 Jobs AstraZeneca - 36 Jobs Celgene - 32 Jobs IQVIA Biotech - 21 Jobs Oxford BioMedica (UK) Limited - 16 Jobs Lonza - 16 Jobs Grunenthal GmbH - 14 Jobs Register and Upload Your CV Now
Covance - 388 Jobs BSI Group - 167 Jobs PRA Health Sciences - 105 Jobs PPD- 81 Jobs Roche - 77 Jobs Synteract- 74 Jobs United BioSource Corporation. - 69 Jobs Cytel - 68 Jobs Syneos Health - 52 Jobs CROMSOURCE - 51 Jobs IQVIA - 36 Jobs AstraZeneca - 36 Jobs Celgene - 32 Jobs IQVIA Biotech - 21 Jobs Oxford BioMedica (UK) Limited - 16 Jobs Lonza - 16 Jobs Grunenthal GmbH - 14 Jobs Register and Upload Your CV Now
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes.
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes. Through a series of talks, the speakers provided fresh perspectives on living with type 1 diabetes, whilst experts in the area provided insights on the importance of removing barriers and embracing new technologies. Novo Nordisk UK is a key sponsor of the event, which took place at the Royal College of Physicians, London. Actor…
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes. Through a series of talks, the speakers provided fresh perspectives on living with type 1 diabetes, whilst experts in the area provided insights on the importance of removing barriers and embracing new technologies. Novo Nordisk UK is a key sponsor of the event, which took place at the Royal College of Physicians, London. Actor…
22-Jul-2019
Regulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future employers and get essential advice from some of the most respected and influential leaders in the field of regulatory affairs
21 May 2019 | University of Hertfordshire, Hatfield, UKRegulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future…
21 May 2019 | University of Hertfordshire, Hatfield, UKRegulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future…
12-Apr-2019
PharmiWeb.jobs a new jobs board
PharmiWeb are very excited to be launch the new version of our world class Job Board PharmiWeb.jobs, as well as the latest Pharma News Portal PharmiWeb.com.To search for the best selections of Pharma Jobs in Europe visit pharmiweb.jobsTo find the widest range of pharma news, events and articles, search on this site! PharmiWeb are partnering with numerous providers and organisations such as: Jooble To find our Jobs and other similar jobs please check Jooble. Jooble is a job search engine operated in 70 countries worldwide.
PharmiWeb are very excited to be launch the new version of our world class Job Board PharmiWeb.jobs, as well as the latest Pharma News Portal PharmiWeb.com.To search for the best selections of Pharma Jobs in Europe visit pharmiweb.jobsTo find the widest range of pharma news, events and articles, search on this site! PharmiWeb are partnering with numerous providers and organisations such as: Jooble To find our Jobs and other similar jobs please check Jooble. Jooble is a job search engine operated in 70 countries worldwide.
